FDA Slaps Ban On API Supplied By India’s Laxachem

Indian drug companies under the US Food and Drug Administration scanner for non- compliance of quality standards have yet another thing to worry about. The drug regulator which so far had banned products of certain companies for quality issues has now accused an Indian manufacturer of causing a bacterial outbreak.

The USFDA has banned products of Laxachem Organics, a maker of active pharmaceutical ingredients, from US markets as part of the effort to arrest the Burkholderia cepacia ..

Back to news